Porovnat metody

	Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)	ALSFRS-R (Revised škála funkčního hodnocení ALS)
Obor	Neurologie	Neurologie
Rodina	Process / pipeline	Process / pipeline
Rok vzniku	2001	1999
Tvůrce	Mark I. Bennett, University of Leeds	James M. Cedarbaum, NIH/NINDS
Typ	Hybrid questionnaire and clinician examination	Clinician-rated and patient-reported hybrid
Původní zdroj	Bennett, M. I. (2001). The LANSS Pain Scale: The Leeds Assessment of Neuropathic Symptoms and Signs. Pain, 92(1-2), 147-157.	Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences, 169(1-2), 13-21.
Další názvy	LANSS Pain Scale, Leeds Neuropathic Symptoms	ALS FRS-R, Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised
Příbuzné	4	4
Shrnutí	The LANSS is a brief seven-item hybrid screening and diagnostic tool designed to differentiate neuropathic pain from non-neuropathic (nociceptive) pain. Developed by Mark Bennett at the University of Leeds in 2001, it combines five patient-reported symptom items with two clinician-performed neurological examination findings. With a sensitivity of 82% and specificity of 80%, LANSS is among the most accurate tools for identifying whether a patient's pain has a neuropathic component, making it invaluable in clinical practice and research settings where pain etiology classification is essential.	The ALSFRS-R is a 12-item clinician-administered functional rating scale designed to assess disease progression and functional status in amyotrophic lateral sclerosis (ALS). Introduced by Cedarbaum and colleagues in 1999, it expands upon the original ALSFRS by incorporating respiratory function assessment. It is the primary outcome measure in ALS clinical trials and routine clinical monitoring, providing quantitative tracking of disease decline that predicts survival and guides management decisions.